National Health Investors NHI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value at other companies

Mondelez InternationalMDLZ

$64M-68.8%

MSCIMSCI

$5.47M-58.4%

General DynamicsGD

$1.08B+80.1%

AmetekAME

$154.9M+32.2%

The Travelers CompaniesTRV

$763M+25.1%

General DynamicsGD

$817M+57.7%

Other financials

Income statement

See full

Revenue$115.1M+28.9%

Net income$40.1M+17.4%

EPS (diluted)$0.82+10.8%

Balance sheet

See full

Cash & equivalents$24.9M-81.8%

Total debt$1.4B+8.4%

Total equity$1.5B+6.2%

Total assets$2.9B+3.8%

Cash flow

See full

Operating cash flow$53.4M+15.0%

Valuation

See full

Market cap$3.54B+16.1%

Profitability

See full

Operating margin50.1%—

Net margin36.9%-4.3pp

FCF margin70.1%—

Returns & leverage

See full

Return on equity10.1%-0.5pp

Debt / equity0.9×0.0×

Where this comes from

Reported directly by National Health Investors in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: National Health Investors’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about National Health Investors's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is National Health Investors's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?: National Health Investors (NHI) reported share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value of $4.3M in Q1 2026.
How has National Health Investors's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value changed year-over-year?: National Health Investors's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value decreased by 60.6% year-over-year, from $10.9M to $4.3M.